Managing blood thinners for older adults with heart rhythm issues
Official title: A trial of Pharmacist management of Oral anticoagulation THerapy versus Enhanced usual CARe in the communitY for AF (APOTHECARY AF)
Funded at Cedars-Sinai Medical Center · NIH-10687502 · Data updated 2026-11-12
This study is looking at how having pharmacists help manage blood-thinning medications can better support older adults with atrial fibrillation, aiming to lower their risk of stroke and improve their overall health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | September 30, 2022 |
| Project end | August 31, 2025 |
| Funding year | 2022 |
| Award (this year) | $843,702 |
| NIH project number | 1R56AG075954-01A1 |
| Project ID | NIH-10687502 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults diagnosed with atrial fibrillation who are at risk for stroke and may benefit from improved anticoagulation management.
✕Less likely to help
Patients who do not have atrial fibrillation or those who are not on anticoagulation therapy may not receive any benefit from this research.
What this research studies
This research investigates how pharmacist management of oral anticoagulation therapy can improve care for older adults with atrial fibrillation, a common heart rhythm disorder. The study compares this pharmacist-led approach to enhanced usual care in community settings. By focusing on improving the delivery of anticoagulation therapy, the research aims to reduce the risk of stroke and enhance patient outcomes. Patients will receive tailored medication management to ensure they are on the right drugs and dosages.
Why it matters
Potential benefit: If successful, this research could lead to better management of anticoagulation therapy, reducing the risk of stroke and improving the quality of life for older adults with atrial fibrillation.
How similar studies have gone: Previous research has shown that pharmacist-led interventions can significantly improve outcomes in chronic disease management, indicating a promising approach for this study.
Where this research is happening
-
Cedars-Sinai Medical Center
Los Angeles, United States Active
Researchers
- Principal investigator: Sandhu, Roopinder — Cedars-Sinai Medical Center
- Study coordinator: Sandhu, Roopinder
Related research
Other NIH-funded projects on the same topics.
-
Lipid signals that control acetyl-CoA and fat metabolism in NAFLD
A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).
-
Them1’s role in fat metabolism and MASLD progression
Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.
-
Biomarker-guided Immunosuppression in Kidney Transplant Patients
A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.
-
Alpha5 integrin's role in ALS: how a cell switch worsens disease
Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.
-
Chlamydia pneumoniae infection and Alzheimer's disease progression
This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.
-
Them1 Inhibitors to Help Treat Fatty Liver Disease
Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.